FGAM
ALXN
Financial Gravity Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-11
| Closed | -$184K | – | 1040 |
|
|
2021
Q2 | $184K | Sell |
11
-6
| -35% | -$100K | 0.07% | 205 |
|
|
2021
Q1 | $2.53K | Sell |
17
-49
| -74% | -$7.28K | 0.05% | 223 |
|
|
2020
Q4 | $10K | Buy |
+66
| New | +$10K | 0.01% | 182 |
|
|
2020
Q2 | – | Sell |
-429
| Closed | -$38.5K | – | 1038 |
|
|
2020
Q1 | $38.5K | Sell |
429
-292
| -40% | -$26.2K | 0.12% | 78 |
|
|
2019
Q4 | $108K | Sell |
721
-365
| -34% | -$54.7K | 0.07% | 291 |
|
|
2019
Q3 | $106K | Sell |
1,086
-244
| -18% | -$23.8K | 0.09% | 197 |
|
|
2019
Q2 | $174K | Sell |
1,330
-282
| -17% | -$36.9K | 0.14% | 159 |
|
|
2019
Q1 | $218K | Buy |
+1,612
| New | +$218K | 0.18% | 124 |
|
|
2018
Q3 | $215K | Buy |
1,919
+297
| +18% | +$33.3K | 0.23% | 103 |
|
|
2018
Q2 | $193K | Sell |
1,622
-223
| -12% | -$26.5K | 0.18% | 122 |
|
|
2018
Q1 | $211K | Buy |
+1,845
| New | +$211K | 0.22% | 85 |
|